<DOC>
	<DOCNO>NCT02179281</DOCNO>
	<brief_summary>The aim study prove whether use SmartGuard feature MiniMed system significantly reduce hypoglycemic excursion thus provide proactive protection user .</brief_summary>
	<brief_title>Prevention Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump Children</brief_title>
	<detailed_description>This randomize two-arm parallel control open label study conduct two site , Slovenia Israel . It investigator initiate pediatric clinical study . Study conduct pediatric population two week , follow 3 day Run-in period allow patient get familiar study device CGM ( SmartGuard OFF ) . Patients ask continuously wear study device 14 day , set study staff accord randomization specific group . They provide diary entering daily activity , food consumption ( carb count ) eventual adverse event .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Informed consent sign parent/legal guardian inform assent sign study participant prior study entry Diagnosed Type 1 DM least 12 month prior signature Patient Informed Consent ( PIC ) . Age 818 year old ( inclusive ) signature PIC Treated CSII without CGM least 3 month prior signature PIC , use LGS last two week prior signature PIC . HbA1c value screen visit â‰¤10 % Knowledgeable use CSII , administer treatment , adjust insulin accord diet exercise Performance average four ( 4 ) SMBG per day , evidence patient file , late insulin pump glucose meter download Treated investigator 's centre least 6 month prior signature PIC . Willing undergo study procedure Hearing vision impairment glucose display alarm recognize . Alcohol drug abuse . Noncompliance diabetes selfmonitoring disease management Documented cutaneous allergy disease ( allergy sensor component sensor , psoriasis , staphylococcus , exanthema etc. ) . Any documented concomitant chronic disease know affect diabetes control ( e.g . alter renal function , active cancer undergo treatment , Crohn 's disease , ulcerative colitis , Mb Addison disease ) concomitant pharmacological treatment might modify glycemic value ( e.g . chronic corticosteroid therapy ) , Eating disorder morbid obesity ( define adult : BMI &gt; 35 child BMI &gt; 2 SD age ) assess investigator . Any medical , social psychological condition , investigator 's opinion , make patient unable comply study protocol study procedure . Patient reliable support person . Participation another clinical study , ongoing complete less 2 month prior signature PIC . Pregnancy ( per investigator judgment , include pregnancy test necessary )</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>